These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 17595539)
1. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Airley RE; Mobasheri A Chemotherapy; 2007; 53(4):233-56. PubMed ID: 17595539 [TBL] [Abstract][Full Text] [Related]
2. Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment. Barron CC; Bilan PJ; Tsakiridis T; Tsiani E Metabolism; 2016 Feb; 65(2):124-39. PubMed ID: 26773935 [TBL] [Abstract][Full Text] [Related]
3. [The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors]. Jóźwiak P; Lipińska A Postepy Hig Med Dosw (Online); 2012 Jan; 66():165-74. PubMed ID: 22470192 [TBL] [Abstract][Full Text] [Related]
4. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Evans A; Bates V; Troy H; Hewitt S; Holbeck S; Chung YL; Phillips R; Stubbs M; Griffiths J; Airley R Cancer Chemother Pharmacol; 2008 Mar; 61(3):377-93. PubMed ID: 17520257 [TBL] [Abstract][Full Text] [Related]
5. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. Pedersen MW; Holm S; Lund EL; Højgaard L; Kristjansen PE Neoplasia; 2001; 3(1):80-7. PubMed ID: 11326319 [TBL] [Abstract][Full Text] [Related]
6. Expression of glucose transporters in cancers. Szablewski L Biochim Biophys Acta; 2013 Apr; 1835(2):164-9. PubMed ID: 23266512 [TBL] [Abstract][Full Text] [Related]
7. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis. Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia inducible factor-1 and facilitative glucose transporters GLUT1 and GLUT3: putative molecular components of the oxygen and glucose sensing apparatus in articular chondrocytes. Mobasheri A; Richardson S; Mobasheri R; Shakibaei M; Hoyland JA Histol Histopathol; 2005 Oct; 20(4):1327-38. PubMed ID: 16136514 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia preconditioning protects neuronal cells against traumatic brain injury through stimulation of glucose transport mediated by HIF-1α/GLUTs signaling pathway in rat. Wu X; Wang C; Wang J; Zhu M; Yao Y; Liu J Neurosurg Rev; 2021 Feb; 44(1):411-422. PubMed ID: 31897883 [TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. Macheda ML; Rogers S; Best JD J Cell Physiol; 2005 Mar; 202(3):654-62. PubMed ID: 15389572 [TBL] [Abstract][Full Text] [Related]
11. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer. Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102 [TBL] [Abstract][Full Text] [Related]
12. Glucose transporters in cancer - from tumor cells to the tumor microenvironment. Ancey PB; Contat C; Meylan E FEBS J; 2018 Aug; 285(16):2926-2943. PubMed ID: 29893496 [TBL] [Abstract][Full Text] [Related]
13. Metabolic phenotype of bladder cancer. Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021 [TBL] [Abstract][Full Text] [Related]
14. Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia. Busk M; Horsman MR; Kristjansen PE; van der Kogel AJ; Bussink J; Overgaard J Int J Cancer; 2008 Jun; 122(12):2726-34. PubMed ID: 18351643 [TBL] [Abstract][Full Text] [Related]
15. Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. Baumann MU; Zamudio S; Illsley NP Am J Physiol Cell Physiol; 2007 Jul; 293(1):C477-85. PubMed ID: 17442736 [TBL] [Abstract][Full Text] [Related]
16. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cao X; Fang L; Gibbs S; Huang Y; Dai Z; Wen P; Zheng X; Sadee W; Sun D Cancer Chemother Pharmacol; 2007 Mar; 59(4):495-505. PubMed ID: 16906425 [TBL] [Abstract][Full Text] [Related]
17. Regulation of glucose transport by hypoxia. Zhang JZ; Behrooz A; Ismail-Beigi F Am J Kidney Dis; 1999 Jul; 34(1):189-202. PubMed ID: 10401038 [TBL] [Abstract][Full Text] [Related]
18. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Airley R; Loncaster J; Davidson S; Bromley M; Roberts S; Patterson A; Hunter R; Stratford I; West C Clin Cancer Res; 2001 Apr; 7(4):928-34. PubMed ID: 11309343 [TBL] [Abstract][Full Text] [Related]
19. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Chen JQ; Russo J Biochim Biophys Acta; 2012 Dec; 1826(2):370-84. PubMed ID: 22750268 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation. Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]